Clinical Trials
- Immune System
Yale Lupus and Connective Tissue Disease Bio-Repository / Yale Rheumatology Bio-Repository
- Ages18 years and older
- GenderBoth
- Diabetes
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22)
- Ages3 years and older
- GenderBoth
- Diabetes
test
- Ages18 years and older
- GenderBoth
- Diabetes
Metabolic Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes
- Ages12 years - 24 years
- GenderBoth
- Children's Health, Diabetes, Endocrine System
Pathway to Prevention Study
- Ages1 year - 45 years
- GenderBoth
- Diabetes
Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab (PROTECT)
- Ages8 years - 17 years
- GenderBoth
- Diabetes
TrialNet TOPPLE Study for People with Type 1 Diabetes
- Ages18 years - 45 years
- GenderBoth
- Diabetes
FreeStyle Libre 2 Flash Glucose Monitoring System Intervention Phase Study for Pediatric Patients
- Ages4 years - 17 years
- GenderBoth
- Diabetes
Virtual Physical Activity for Type 1 Diabetes
- Ages14 years - 19 years
- GenderBoth
- Blood Disorders, COVID-19 Inpatient, COVID-19 Outpatient
Mechanisms for restoration of hypoglycemia awareness